Linus Health

Country:
USA
Founding year:
2019

Linus Health is a neurotechnology company developing software platforms to support early detection, diagnosis, and management of cognitive impairment and neurodegenerative disease. The company focuses on translating validated cognitive science into scalable digital tools that can be deployed in routine clinical care.

Its platform combines tablet-based cognitive assessments with analytics and clinician-facing dashboards to generate objective measures of cognitive function. These tools are designed to support screening, longitudinal monitoring, and care planning, while integrating into existing clinical workflows rather than replacing specialist evaluation.

Linus Health’s technology is used in clinical and healthcare system settings to support dementia care pathways, including early identification, monitoring disease progression, and informing treatment decisions. The company positions its platform as clinical decision-support infrastructure rather than a consumer cognitive training product.

Tools and Infrastructure
Diagnostics
Decision Support

Neurofounders Insights

Modality:
Software
Form Factor:
Software/app
Interface Depth:
Software
Indication:
Dementia/impairment
Target user:
Clinicians
Regulatory stage:
FDA cleared (501k)

Series B

Linus Health is one of the more commercially advanced digital cognitive assessment platforms, combining validated tests, decision support, and acquired biomarker capabilities such as speech analytics. Its positioning is strongest as a clinician-facing dementia workflow platform rather than a breakthrough biomarker company.

Related companies

Articles featuring

Linus Health

No articles yet!

Press releases

No press releases published yet.